Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A qualitative analysis of the experiences of pioneering females in pediatric otolaryngology.

International journal of pediatric otorhinolaryngology·2026
Same author

Positional obstructive sleep apnea in pediatric down syndrome: Prevalence and therapy implications.

International journal of pediatric otorhinolaryngology·2026
Same author

Polysomnographic Characteristics of Sleep Architecture in Children With Obstructive Sleep Apnea.

The Annals of otology, rhinology, and laryngology·2024
Same author

Endoscopic pediatric endonasal retrieval of transorbital projectile: An illustrative multimedia report.

American journal of otolaryngology·2023
Same author

Women Surgeons Who Contributed to the Development of Pediatric Otolaryngology in the United States.

The Laryngoscope·2023
Same author

When is the Optimal Time to Reduce Pediatric Nasal Bone Fractures?

The Laryngoscope·2023
Same journal

Tranexamic acid and beyond: A systematic review of pediatric post-tonsillectomy hemorrhage protocols and introduction of a universal management guideline.

International journal of pediatric otorhinolaryngology·2026
Same journal

Percutaneous contralateral vocal fold lateralization in pediatric bilateral vocal fold paralysis.

International journal of pediatric otorhinolaryngology·2026
Same journal

Outcomes of single-stage excision in infected preauricular sinus: a retrospective cohort study.

International journal of pediatric otorhinolaryngology·2026
Same journal

Therapy changes in the treatment of subglottic laryngitis: A 30-year experience in Croatia.

International journal of pediatric otorhinolaryngology·2026
Same journal

Regional barriers and innovative solutions in the medical rehabilitation of children with cochlear implants in Uzbekistan: A telemonitored home-based versus center-based comparative study.

International journal of pediatric otorhinolaryngology·2026
Same journal

Long-term quality of life outcomes after tympanostomy tube by surgical indication.

International journal of pediatric otorhinolaryngology·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

Age specific differences in pediatric obstructive sleep apnea.

Debra M Don1, Kenneth A Geller, Jeffrey A Koempel

  • 1Division of Pediatric Otolaryngology and Pulmonology, Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA. ddon@chla.usc.edu

International Journal of Pediatric Otorhinolaryngology
|May 5, 2009
PubMed
Summary
This summary is machine-generated.

Younger children, particularly those under 3, show a higher incidence of severe obstructive sleep apnea (OSA). This age group also experiences more central apneas, suggesting a need for careful monitoring post-surgery.

Related Experiment Videos

Last Updated: Jun 23, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

Area of Science:

  • Pediatric Sleep Medicine
  • Respiratory Physiology
  • Otolaryngology

Background:

  • Obstructive sleep apnea (OSA) severity may differ between younger and older children.
  • Younger children might face higher respiratory risks post-tonsillectomy and adenoidectomy.
  • Limited studies have explored the age-related correlation with OSA severity.

Purpose of the Study:

  • To investigate age-specific variations in obstructive sleep apnea severity among pediatric patients.
  • To determine if younger children exhibit distinct OSA patterns compared to older children.

Main Methods:

  • Retrospective chart review of children aged 1-18 diagnosed with OSA via polysomnography.
  • Analysis included apnea-hypopnea index (AHI), oxygen saturation, end-tidal CO2, and apnea types.
  • Children were grouped by age: 1-2, 3-5, 6-11, and 12-18 years.

Main Results:

  • While a trend suggested more severe OSA in younger children, statistical significance was limited for most parameters.
  • Analysis of variance revealed significant differences (p<0.01) in AHI and apnea types between the 1-2 year olds and older groups.
  • Children aged 1-2 years showed a higher proportion in moderate to severe OSA categories (p<0.01).

Conclusions:

  • Children under 3 years old demonstrate a predisposition for more severe obstructive sleep apnea.
  • Central apneas are also more prevalent in this younger demographic.
  • Age-related anatomical and physiological differences may explain these findings, supporting post-adenotonsillectomy observation in young children.